Abstract
Purpose: The aim of this study was established as investigating the patients with differentiated thyroid cancers diagnosed initially with distant metastasis.
Materials and Methods: The medical records of 531 patients with differentiated thyroid cancers who were treated and followed up in departments of general surgery and nuclear medicine between February 1997 and February 2008 were retrospectively analyzed.
Results: There were 9 patients who were initially diagnosed with distant metastasis. The locations of metastases were bone in 7 patients, lungs in 1 patient and scalp in 1 patient. Thyroidectomies were total in 8 patients and near total in one. The types of cancers were papillary in 5 and follicular in four patients. All the patients received radioactive iodine treatment. The median survival time of the nine patients was determined as 103 months. The resections of metastatic lesions in 4 patients with curative intent did not effect survival significantly (p = 0.743).
Conclusion: The patients with differentiated thyroid cancers may have long term survival rates with aggressive treatments even with the presence of distant metastasis. Radioactive iodine and thyroid-stimulating hormone suppression with thyroxine subsequent to total thyroidectomy constitute the recommended treatment protocol for these kind of patients.
Keywords:
Thyroid cancers, distant metastasis, thyroid
References
1Mizukami Y, Michigishi T, Nonomura A, et al. Distant metastases in differentiated thyroid carcinoma: a clinical and pathologic study. Hum Pathol 1990;21:283–290.
2Schlumberger M, Tubiana M, De Vathaire F, et al. Long term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986;63:960–967.
3Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501–508.
4Wood WJ, Singletary SE, Hickey RC. Current results of treatment for distant metastatic well-differentiated thyroid carcinoma. Arch Surg 1989;124:1374–1377.
5Shoup M, Stojadinovic A, Nissan A, et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 2003;197: 91–97.
6Lin JD, Huang MJ, Juang JH, et al. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 1999;9:1227–1235.
7Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 1994;18:600–604.
8Mishra A, Kanta Mishra S, Agarwal A, et al. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area. World J Surg 2002;26:153–157.
9Eustatia-Rutten CF, Corssmit EP, Biermasz NR. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91:313-319.
10Lerch H, Schober O, Kuwert T, Saur HB. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 1997;15:2067-2075.
11Pomorski L, Bartos M. Metastasis as the first sign of thyroid cancer. Neoplasma 1999;46: 309-312.
12Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 1997;174:474-476.
13Stojadinovic A, Shoup M, Ghossein RA. The role of operations for distantly metastatic well-differentiated thyroid carcinoma. Surgery 2002;131:636-643
14Niederle B, Roka R, Schemper M. Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results. Surgery 1986;100:1088-1097.
15Benbassat CA, Mechlis-Frish S, Hirsch D. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer. World J Surg 2006;30:1088-1095.
16Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 2005;63:87-93.
17Doherty GM. Follicular neoplasms of the thyroid. In: Clark OH, Duh QY. Textbook of endocrine surgery. 1st ed. Philadelphia: WB Saunders 1997: 95-102.
18Erbil Y. Diferansiye tiroid kanserinde cerrahi tedavi. Endokrinolojide Diyalog Dergisi 2005;2:128-130.
19Baudin E, Do Cao C, Cailleux AF. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 2003 ;88:1107-1111.
20Azal Ö. Serum tiroglobulin ölçümü ve klinik kullanımı. Türkiye Klinikleri Cerrahi Tıp Bilimleri 2005; 1: 7-13.
21Miccoli P, Pacini F. Papillary and follicular carcinoma: Surgical and radioiodine treatment of distant metastases. In: Clark OH, Duh QY. Textbook of endocrine surgery. 1st ed. Philadelphia: WB Saunders, 1997: 119-125.
22Pacini F, Lippi F, Formica N. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28:1888-1891.
23Petrich T, Widjaja A, Musholt TJ. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age. Eur J Nucl Med 2001;28:203-208.
